Concepedia
Statistics
Publications
9
Citations
490
H-Index
Active since
2013
Affiliations
Cleveland Clinic(Current)
Case Western Reserve University
Icahn School of Medicine at Mount Sinai
Cleveland Clinic Lerner College of Medicine
Cancer Institute (WIA)
Rita Tohmé is an author at Cleveland Clinic specializing in medicine, cancer research, and cell biology.
Top concepts
MedicineCell BiologyCancer ResearchTumor BiologyCancer BiologyTumor MicroenvironmentOncologyCell ProliferationCancer Cell BiologyHealth
Publications per year
2013–2021
Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth
Jaya Sangodkar, Abbey Perl, Rita Tohmé et al. · Journal of Clinical Investigation · 2017 · 196 citations · Full text
Kras-driven Tumor Growth, Cell Proliferation, Cancer Biology +18
Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network
Xiaorong Gu, Rita Tohmé, Benjamin Tomlinson et al. · Leukemia · 2020 · 99 citations · Full text
Direct activation of PP2A for the treatment of tyrosine kinase inhibitor–resistant lung adenocarcinoma
Rita Tohmé, Sudeh Izadmehr, Sai Gandhe et al. · JCI Insight · 2019 · 68 citations · Full text
Direct Activation, Tumor Biology, Signaling Pathway +17
A pilot clinical trial of the cytidine deaminase inhibitor tetrahydrouridine combined with decitabine to target DNMT1 in advanced, chemorefractory pancreatic cancer.
Davendra Sohal, Smitha Krishnamurthi, Rita Tohmé et al. · PubMed · 2020 · 29 citations · Full text
PBRM1 loss in kidney cancer unbalances the proximal tubule master transcription factor hub to repress proximal tubule differentiation
Xiaorong Gu, Francis Enane, Rita Tohmé et al. · Cell Reports · 2021 · 21 citations · Full text
Urology, Signaling Pathway, Release Rcc Cells +14
1–5 of 9